Enovis Corporation
Last updated September 27, 2026
Organization details
- Legal name
- Enovis Corporation
- Former names
- Colfax CORP
- Ownership
- Public
- Status
- Active
- SIC code
- 3842 — Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Lewisville
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ENOV
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001420800
- EIN
- 54-1887631
Board of directors
-
A. Clayton Perfall · DirectorSince 2023
-
Angela S. Lalor · DirectorSince 2023
-
Barbara W. Bodem · DirectorSince 2023
-
Brady Shirley · DirectorSince 2023
-
Christine Ortiz · DirectorSince 2023
-
Damien McDonald · Director · Chief Executive OfficerSince 2025
-
Liam Kelly · DirectorSince 2023
-
Matthew L. Trerotola · Director · CEOSince 2023
-
Mitchell P. Rales · DirectorSince 2023
-
Philip Okala · DirectorSince 2023
-
Rajiv Vinnakota · DirectorSince 2023
-
Sharon L. Wienbar · DirectorSince 2023
Chief executives
Matthew L. Trerotola
· CEO
Dates unknown
Damien McDonald
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of May 21, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.4%
-
98.4%
-
99.2%
-
99.4%
-
99.6%
-
99.9%
-
99.9%
-
99.9%
-
99.9%
Board connections
8 of this board's directors also sit on 11 other boards.
- via Mitchell P. Rales and Rajiv Vinnakota
- via Matthew L. Trerotola
- via Barbara W. Bodem
- via Mitchell P. Rales
- via Sharon L. Wienbar
- via Damien McDonald
- via Christine Ortiz
- via Barbara W. Bodem
- via Sharon L. Wienbar
- via Matthew L. Trerotola
- via Liam Kelly
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $762,432
- 18 purchases by 3 insiders
- Sold, last 12 months
- $45,298
- 4 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 4, 2026 | Damien McDonald Director, Officer (Chief Executive Officer) | Open-market purchase | +13,035 | $19.15 | $249,620 |
| Sep 4, 2026 | Engert Oliver Officer (Chief Administrative Officer) | Open-market purchase | +2,660 | $18.80 | $50,008 |
| Sep 3, 2026 | Engert Oliver Officer (Chief Administrative Officer) | Open-market purchase | +5,140 | $19.46 | $100,024 |
| Sep 2, 2026 | Engert Oliver Officer (Chief Administrative Officer) | Open-market purchase | +2,458 | $20.32 | $49,947 |
| Jun 30, 2026 | Christine Ortiz Director | Grant or award | +846 | — | — |
| Jun 15, 2026 | Engert Oliver Officer (Chief Administrative Officer) | Open-market purchase | +1,000 | $20.92 | $20,920 |
| Jun 11, 2026 | Engert Oliver Officer (Chief Administrative Officer) | Open-market purchase | +200 | $20.99 | $4,198 |
| Jun 11, 2026 | Engert Oliver Officer (Chief Administrative Officer) | Open-market purchase | +1,000 | $21.75 | $21,750 |
| Jun 10, 2026 | Engert Oliver Officer (Chief Administrative Officer) | Open-market purchase | +1,000 | $23.00 | $23,000 |
| Jun 1, 2026 | Engert Oliver Officer (Chief Administrative Officer) | Open-market purchase | +1,000 | $22.22 | $22,220 |
| May 19, 2026 | Brady Shirley Director | Grant or award | +9,346 | — | — |
| May 19, 2026 | Barbara W. Bodem Director | Grant or award | +9,346 | — | — |
| May 19, 2026 | Philip Okala Director | Grant or award | +9,346 | — | — |
| May 19, 2026 | Christine Ortiz Director | Grant or award | +9,346 | — | — |
| May 19, 2026 | Angela S. Lalor Director | Grant or award | +9,346 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.